BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7647011)

  • 1. Monoclonal gammopathy of undetermined significance: chromosome changes are a common finding within bone marrow plasma cells.
    Zandecki M; Obein V; Bernardi F; Soenen V; Flactif M; Laï JL; François M; Facon T
    Br J Haematol; 1995 Jul; 90(3):693-6. PubMed ID: 7647011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Several cytogenetic subclones may be identified within plasma cells from patients with monoclonal gammopathy of undetermined significance, both at diagnosis and during the indolent course of this condition.
    Zandecki M; Laï JL; Geneviève F; Bernardi F; Volle-Rémy H; Blanchet O; François M; Cosson A; Bauters F; Facon T
    Blood; 1997 Nov; 90(9):3682-90. PubMed ID: 9345053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
    Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A
    Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interphase fluorescence in situ hybridization identifies chromosomal abnormalities in plasma cells from patients with monoclonal gammopathy of undetermined significance.
    Drach J; Angerler J; Schuster J; Rothermundt C; Thalhammer R; Haas OA; Jäger U; Fiegl M; Geissler K; Ludwig H; Huber H
    Blood; 1995 Nov; 86(10):3915-21. PubMed ID: 7579361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal abnormalities in systemic amyloidosis.
    Fonseca R; Ahmann GJ; Jalal SM; Dewald GW; Larson DR; Therneau TM; Gertz MA; Kyle RA; Greipp PR
    Br J Haematol; 1998 Dec; 103(3):704-10. PubMed ID: 9858220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance.
    Königsberg R; Ackermann J; Kaufmann H; Zojer N; Urbauer E; Krömer E; Jäger U; Gisslinger H; Schreiber S; Heinz R; Ludwig H; Huber H; Drach J
    Leukemia; 2000 Nov; 14(11):1975-9. PubMed ID: 11069034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS.
    Chng WJ; Van Wier SA; Ahmann GJ; Winkler JM; Jalal SM; Bergsagel PL; Chesi M; Trendle MC; Oken MM; Blood E; Henderson K; Santana-Dávila R; Kyle RA; Gertz MA; Lacy MQ; Dispenzieri A; Greipp PR; Fonseca R
    Blood; 2005 Sep; 106(6):2156-61. PubMed ID: 15920009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow up with conventional cytogenetics and band 13q14 interphase/metaphase in situ hybridization monitoring in monoclonal gammopathies of undetermined significance.
    Bernasconi P; Cavigliano PM; Boni M; Astori C; Calatroni S; Giardini I; Rocca B; Caresana M; Crosetto N; Lazzarino M; Bernasconi C
    Br J Haematol; 2002 Aug; 118(2):545-9. PubMed ID: 12139743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trisomy 8 and monosomy 7 detected in bone marrow using primed in situ labeling, fluorescence in situ hybridization, and conventional cytogenetic analyses. A study of 54 cases with hematological disorders.
    Yan J; Zhang XX; Fetni R; Drouin R
    Cancer Genet Cytogenet; 2001 Feb; 125(1):30-40. PubMed ID: 11297765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosomal aberrations are shared by malignant plasma cells and a small fraction of circulating CD19+ cells in patients with myeloma and monoclonal gammopathy of undetermined significance.
    Zojer N; Schuster-Kolbe J; Assmann I; Ackermann J; Strasser K; Hübl W; Drach J; Ludwig H
    Br J Haematol; 2002 Jun; 117(4):852-9. PubMed ID: 12060120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperdiploidy is a common finding in monoclonal gammopathy of undetermined significance and monosomy 13 is restricted to these hyperdiploid patients.
    Brousseau M; Leleu X; Gerard J; Gastinne T; Godon A; Genevieve F; Dib M; Lai JL; Facon T; Zandecki M;
    Clin Cancer Res; 2007 Oct; 13(20):6026-31. PubMed ID: 17947464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of p53 deletions in bone marrow plasma cells of patients with monoclonal gammopathy of undetermined significance.
    Ackermann J; Meidlinger P; Zojer N; Gisslinger H; Ludwig H; Huber H; Drach J
    Br J Haematol; 1998 Dec; 103(4):1161-3. PubMed ID: 9886335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma.
    Kaufmann H; Ackermann J; Baldia C; Nösslinger T; Wieser R; Seidl S; Sagaster V; Gisslinger H; Jäger U; Pfeilstöcker M; Zielinski C; Drach J
    Leukemia; 2004 Nov; 18(11):1879-82. PubMed ID: 15385925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interphase fluorescence in situ hybridization in multiple myeloma and monoclonal gammopathy of undetermined significance without and with positive plasma cell identification: analysis of 192 cases from the Region of Southern Denmark.
    Christensen JH; Abildgaard N; Plesner T; Nibe A; Nielsen O; Sørensen AG; Kerndrup GB;
    Cancer Genet Cytogenet; 2007 Apr; 174(2):89-99. PubMed ID: 17452249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of cytomorphology, immunophenotyping, and interphase fluorescence in situ hybridization in 381 patients with monoclonal gammopathy of undetermined significance and 301 patients with plasma cell myeloma.
    Bacher U; Haferlach T; Kern W; Alpermann T; Schnittger S; Haferlach C
    Cancer Genet Cytogenet; 2010 Dec; 203(2):169-75. PubMed ID: 21156229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA aneuploidy, increased proliferation and nuclear area of plasma cells in monoclonal gammopathy of undetermined significance and multiple myeloma.
    Leo E; Kropff M; Lindemann A; Steinfurth G; Esselborn H; Rossner R; Adler CP; Böcking A
    Anal Quant Cytol Histol; 1995 Apr; 17(2):113-20. PubMed ID: 7612131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Random aneuploidy in neoplastic and pre-neoplastic diseases, multiple myeloma, and monoclonal gammopathy.
    Amiel A; Gronich N; Yukla M; Suliman S; Josef G; Gaber E; Drori G; Fejgin MD; Lishner M
    Cancer Genet Cytogenet; 2005 Oct; 162(1):78-81. PubMed ID: 16157205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of monoclonal gammopathy of undetermined significance and multiple myeloma using flow cytometric characteristics of plasma cells.
    Sezer O; Heider U; Zavrski I; Possinger K
    Haematologica; 2001 Aug; 86(8):837-43. PubMed ID: 11522540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel three-color, clone-specific fluorescence in situ hybridization procedure for monoclonal gammopathies.
    Ahmann GJ; Jalal SM; Juneau AL; Christensen ER; Hanson CA; Dewald GW; Greipp PR
    Cancer Genet Cytogenet; 1998 Feb; 101(1):7-11. PubMed ID: 9460493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interphase fluorescence in situ hybridization (FISH) as a powerful tool for the detection of aneuploidy in multiple myeloma.
    Flactif M; Zandecki M; Laï JL; Bernardi F; Obein V; Bauters F; Facon T
    Leukemia; 1995 Dec; 9(12):2109-14. PubMed ID: 8609724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.